Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 380 participants.

Also called NCT05657444

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 380 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05657444
Other papers using this trial's data
  • Intra-arterial tenecteplase during thrombectomy for acute ischemic stroke: the BRETIS-TNK2 trial Nature communications, 2026-11-06 DOI, PubMed 42995186, PMC13743779 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05657444. Randomized; single masking; primary purpose treatment. Start 2023-03-21 (actual); primary completion 2025-03-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II)
Condition
Stroke, Ischemic
Intervention (Drug)
Tenecteplase
Lead sponsor
General Hospital of Shenyang Military Region (class: other)
Collaborator
Cerebrovascular Disease Collaboration & Innovation Alliance of Liaoning (class: not stated)

Record details

Record id
cardio:ct-nct05657444
Content hash
05d2d325723f02edc9eab260aabfb9d855c78f4c9529e528b8fb4e0a4db03353